Undertreated and underdiscussed
Research Linking Ozempic to Blindness Research continues to emerge regarding serious side effects of Ozempic and other GLP-1 receptor agonists: January 2026: Patients Who Experienced Vision Loss After Ozempic Can Make Their Case in Federal Court In December of 2025, the Joint Panel on Multidistrict Litigation chose to centralize lawsuits filed by people who took GLP-1 drugs and then were diagnosed with NAION
the insulin dosing protocol was to blame
Loss of appetite, nausea and vomiting
Patients taking GLP-1 medications should watch for sudden or unexplained changes in vision, including painless vision loss or blurring in one eye, dimming of vision, changes in color perception, or missing areas in their field of view, according to consultant ophthalmic surgeon Mr
That may show up as lower inflammatory markers, better metabolic labs, less visceral fat, improved liver health, or feeling less swollen, fatigued, and inflamed over time